Canopy Growth names Miles Worne as European markets managing director

Published 31/07/2025, 12:38
Canopy Growth names Miles Worne as European markets managing director

SMITHS FALLS, Ontario - Cannabis company Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC), currently valued at $215 million in market capitalization, announced Thursday the appointment of Miles Worne as Managing Director of European Markets, effective August 11, 2025. According to InvestingPro data, the company faces significant challenges with negative EBITDA of -$14.8 million in the last twelve months.

Worne will lead the company’s commercial operations and market execution across Europe, where Canopy Growth aims to strengthen its presence in established medical cannabis markets and build capabilities for future expansion. The expansion comes as the company grapples with a challenging financial position, with InvestingPro analysis showing revenue decline of 9.5% and a concerning cash burn rate.

The new executive brings over 20 years of experience across the cannabis, healthcare, and consumer sectors. He previously served as President of Curaleaf International, where he led the company’s European medical cannabis operations. His background includes senior leadership roles at Glanbia Performance Nutrition and SlimFast International across Europe, North America, and Asia.

"Europe represents one of the most compelling long-term growth opportunities for Canopy Growth," said Luc Mongeau, Chief Executive Officer, in the press release. "With a strong commercial background and deep experience in the cannabis sector navigating complex markets, Miles is well-positioned to help scale our presence in the region."

Canopy Growth’s European operations are supported by EU-GMP certified supply from its Kincardine, Ontario facility and processing and distribution capabilities at its St. Leon-Rot facility in Germany.

The company, which produces cannabis products under brands including Tweed, 7ACRES, and Deep Space, also has operations in Canada, Europe, and Australia, and maintains an interest in U.S. cannabis operator Canopy USA, LLC. While the company maintains a healthy current ratio of 3.12, indicating strong short-term liquidity, InvestingPro analysis reveals deeper financial challenges with a negative return on assets of -54%. For comprehensive insights and additional ProTips on Canopy Growth’s financial health and market position, investors can access the detailed Pro Research Report available on InvestingPro.

In other recent news, Canopy Growth Corporation has announced a strategic plan to reduce its debt by US$50 million through a series of prepayments on its Senior Secured Term Loan. The company has reached an agreement with its lenders to make these prepayments by March 31, 2026. This plan includes a US$25 million payment expected around July 31, followed by US$10 million by December 31, and a final US$15 million by March 31, 2026. Canopy Growth anticipates that these prepayments will decrease its annual interest expenses by approximately US$6.5 million. These recent developments are part of the company’s broader efforts to strengthen its financial position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.